Abstract
Biosynthesis of silver nanoparticles with small size and high stability is particularly beneficial in various biomedical applications. Synthesis of silver nanoparticles by the addition of different reducing agents and stabilizing agents has been reported by several researchers. Stability under physiological conditions and blood compatibility are serious issues when silver colloids are used as therapeutic agents in clinical medicine from the safety point of view, particularly, when silver nanoparticles are reported to be translocated in to the systemic circulation. In the present study, we have synthesized silver nanoparticles, with a particle size ranging from 6 to 20 nm, by a green synthesis method using Zingiber officinale extract which acts as reducing as well as a stabilizing agent. The size distribution and formation of silver nanoparticles were confirmed by dynamic light scattering, UV-visible spectrophotometer, transmission electron microscope, and atomic force microscopy. These nanoparticles were also extremely stable at physiological condition and were blood compatible. Z. officinale is reported to be a more potent antiplatelet agent than aspirin. Its use as vectors for applications in drug delivery, gene delivery or as biosensors, where a direct contact with blood occurs is justified by the present study.
Similar content being viewed by others
References
Sharma, V. K., Yngard, R. A., Lin, Y. (2009). Silver nanoparticles: green synthesis and their antimicrobial activities. Advances in Colloid and Interface Science, 145, 83–96.
Thakkar, K. N., Mhatre, S. S., Parikh, R. Y. (2010). Biological synthesis of metallic nanoparticles. Nanomedicine and Nanotechnology Biology and Medicine, 6(2), 257–262.
Goodsell, D. S. (2004). Bionanotechnology: lessons from nature. Hoboken: Wiley.
Hutter, E., & Fendler, J. H. (2004). Exploitation of localized surface plasmon resonance. Advanced Materials, 16, 1685–1706.
Panacek, A., Kvitek, L., Prucek, R., Kolar, M., Vecerova, R., Pizurova, N., Sharma, V. K., Nevecna, T., Zboril, R. (2006). Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. The Journal of Physical Chemistry. B, 110(33), 16248–16253.
Kholoud, M. M., El-Nour, A., Eftaiha, A., Al-Warthan, A., Reda, A. A. (2010). Synthesis and applications of silver nanoparticles. Arabian Journal of Chemistry, 3(3), 135–140.
Caro, C., Castillo, P. M., Klippstein, R., Pozo, D., Zaderenko, A. P. (2010). Silver nanoparticles: Sensing and imaging applications. In D. P. Perez (Ed.), Silver nanoparticles. ISBN: 978-953-307-028-5, InTech, http://www.intechopen.com/books/silver-nanoparticles/silver-nanoparticles-sensing-and-imaging-applications.
Wu, Q., Cao, H., Luan, Q., Zhang, J., Wang, Z., Warner, J. H., Watt, A. A. R. (2008). Biomolecule-assisted synthesis of water-soluble silver nanoparticles and their biomedical applications. Inorganic Chemistry, 47(13), 5882–5888.
Morones, J. R., Elechiguerra, J. L., Camacho, A., Holt, K., Kouri, J. B., Ramirez, J. T., Yacaman, M. J. (2005). The bactericidal effect of silver nanoparticles. Nanotechnology, 16(10), 2346–2353.
Lok, C. N., Ho, C. M., Chen, R., He, Q. Y., Yu, W. Y., Sun, H., Tam, P. K., Chiu, J. F., Che, C. M. (2007). Silver nanoparticles: partial oxidation and antibacterial activities. Journal of Biological Inorganic Chemistry, 12(4), 527–534.
Ip, M., Lui, S. L., Poon, V. K., Lung, I., Burd, A. (2006). Antimicrobial activities of silver dressings: an in vitro comparison. Journal of Medical Microbiology, 55(Pt 1), 59–63.
Silver, S. (2003). Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiology Reviews, 27(2–3), 341–353.
Arvizo, R. R., Bhattacharyya, S., Kudgus, R. A., Giri, K., Bhattacharya, R., Mukherjee, P. (2012). Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chemical Society Reviews, 41, 2943–2970.
Prasad, T. N. V. K. V., Kambala, V. S. R., Naidu, R. (2011). A critical review on biogenic silver nanoparticles and their antimicrobial activity. Current Nanoscience, 7, 531–544.
Vijayaraghavan, K., & Nalini, S. P. K. (2010). Biotemplates in the green synthesis of silver nanoparticles. Biotechnology Journal, 5, 1098–1110.
Thakkar, K. N., Mhatre, S. S., Parikh, R. Y. (2010). Biological synthesis of metallic nanoparticles. Nanomedicine, 6, 257–262.
Florence, A. T. (2005). Nanoparticle uptake by the oral route: fulfilling its potential? Drug Discovery Today: Technologies, 2, 75–81.
Tang, J., Xiong, L., Wang, S., Wang, J., Liu, L., Li, J., Yuan, F., Xi, T. (2009). Distribution, translocation and accumulation of silver nanoparticles in rats. Journal of Nanoscience and Nanotechnology, 9(8), 4924–4932.
Nurtjahja-Tjendraputra, E., Ammit, A. J., Roufogalis, B. D., Tran, V. H., Duke, C. C. (2003). Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thrombosis Research, 111(4–5), 259–265.
Black, C. D., Herring, M. P., Hurley, D. J., O'Connor, P. J. (2010). Ginger (Zingiber officinale) reduces muscle pain caused by eccentric exercise. The Journal of Pain, 11(9), 894–903.
Sileikaite, A., Prosycevas, I., Puiso, J., Juraitis, A., Guobiene, A. (2006). Analysis of silver nanoparticles produced by chemical reduction of silver salt solution. Materials Science (Medziagotyra), 12(4), 287–291.
Lee, P. C., & Melsel, D. (1982). Asorption and surface-enhanced Raman of dyes on silver and gold sols. Journal of Physical Chemistry, 66, 3391–3395.
ISO Standard (2008). Particle size analysis—dynamic light scattering (DLS), International Organization for Standards, ISO 22412:2008E 2008.
Standard Recommended Practice for the Assessment of the Hemolytic Properties of Materials. (1978). Artificial Organs, 2(3), 318–320.
Comell, D. W., & McLachlan, R. (1972). Natural pungent compounds: IV. Examination of the gingerols, shogaols, paradols and related compounds by thin-layer and gas chromatography. Journal of Chromatography, 67(1), 29–35.
Yang, W. S., Dong, X. Y., Ji, X. H., Wu, H. L., Zhao, L. L., Li, J. (2009). Shape control of silver nanoparticles by stepwise citrate reduction. Journal of Physical Chemistry C, 113(16), 6573–6576.
Goia, D. V. (2004). Preparation and formation mechanisms of uniform metallic particles in homogeneous solutions. Journal of Materials Chemistry, 14, 451–458.
Tejamaya, M., Römer, I., Merrifield, R. C., Lead, J. R. (2012). Stability of citrate, PVP, and PEG coated silver nanoparticles in ecotoxicology media. Environmental Science and Technology. doi:10.1021/es2038596.
Tolaymat, T. M. (2010). An evidence-based environmental perspective of manufactured silver nanoparticle in syntheses and applications: a systematic review and critical appraisal of peer-reviewed scientific papers. The Science of the Total Environment, 408, 999–1006.
Römer, I., White, T. A., Baaloushan, M., Chipman, K., Viant, M. R., Lead, J. R. (2011). Aggregation and dispersion of silver nanoparticles in exposure media for aquatic toxicity tests. Journal of Chromatography A, 1218, 4226–4233.
Xia, Y., & Halas, N. J. (2005). Shape-controlled synthesis and surface plasmonic properties of metallic nanostructures. MRS Bulletin, 30, 338–343.
Kerker, M. (1969). Light and other electromagnetic radiation. New York: Academic.
Bohren, C. D., & Huffman, D. R. (1983). Absorption and scattering of light by small particles. New York: Wiley.
Creighton, J. A., & Eadon, D. G. (1991). Ultraviolet visible absorption-spectra of the colloidal metallic elements. Journal of the Chemical Society, Faraday Transactions, 87(24), 3881–3891.
MacCuspie, R. I. (2011). Colloidal stability of silver nanoparticles in biologically relevant conditions. Journal of Nanoparticle Research, 13(7), 2893–2908.
Jani, P., Halbert, G. W., Langridge, J., Florence, A. T. (1989). The uptake and translocation of latex nanospheres and microspheres after oral-administration to rats. The Journal of Pharmacy and Pharmacology, 41(12), 809–812.
Shakweh, M., Ponchel, G., Fattal, E. (2004). Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery. Expert Opinion on Drug Delivery, 1(1), 141–163.
Nemmar, A., Hoylaerts, M. F., Hoet, P. H., Nemery, B. (2004). Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicology Letters, 149(1–3), 243–253.
Mollnes, T. E., Riesenfeld, J., Garred, P., Nordstrom, E., Hogasen, K., Fosse, E., Gotze, O., Harboe, M. (1995). A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin. Artificial Organs, 19(9), 909–917.
Kaplan, K. L., & Owen, J. (1981). Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood, 57(2), 199–202.
Chandy, T., & Sharma, C. P. (1996). Effect of liposome-albumin coatings on ferric ion retention and release from chitosan beads. Biomaterials, 17, 61–66.
Sharma, C. P. (2001). Blood-compatible materials: a perspective. Journal of Biomaterials Applications, 15(4), 359–381.
Xi, T. F., Tang, J. L., Xiong, L., Zhou, G. F., Wang, S., Wang, J. Y., Liu, L., Li, J. G., Yuan, F. Q., Lu, S. F., Wan, Z. Y., Chou, L. S. (2010). Silver nanoparticles crossing through and distribution in the blood–brain barrier in vitro. Journal of Nanoscience and Nanotechnology, 10(10), 6313–6317.
Tanabe, M., Chen, Y. D., Saito, K., Kano, Y. (1993). Cholesterol-biosynthesis inhibitory component from zingiber-officinale roscoe. Chemical and Pharmaceutical Bulletin, 41(4), 710–713.
Afzal, M., Al-Hadidi, D., Menon, M., Pesek, J., Dhami, M. S. (2001). Ginger: an ethnomedical, chemical and pharmacological review. Drug Metabolism and Drug Interactions, 18(3–4), 159–190.
Akhani, S. P., Vishwakarma, S. L., Goyal, R. K. (2004). Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats. The Journal of Pharmacy and Pharmacology, 56(1), 101–105.
Mulvaney, P. (1996). Surface plasmon spectroscopy of nanosized metal particles. Langmuir, 12(3), 788–800.
Acknowledgments
We are grateful to the Director and the Head BMT Wing of SCTIMST for providing facilities for the completion of this work. This work was supported by the Department of Science & Technology, Govt. of India through the project “Facility for nano/microparticle based biomaterials—advanced drug delivery systems” #8013, under the Drugs & Pharmaceuticals Research Programme.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors K. Praveen Kumar and Willi Paul contributed equally to this work.
Rights and permissions
About this article
Cite this article
Kumar, K.P., Paul, W. & Sharma, C.P. Green Synthesis of Silver Nanoparticles with Zingiber officinale Extract and Study of its Blood Compatibility. BioNanoSci. 2, 144–152 (2012). https://doi.org/10.1007/s12668-012-0044-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12668-012-0044-7